Ontology highlight
ABSTRACT: Aim
To characterize progression of Alzheimer's disease (AD) using proton magnetic resonance spectroscopy ((1)H MRS).Methods
Eleven subjects with mild to moderate AD underwent neurocognitive testing and single-voxel (1)H MRS from the precuneus and posterior cingulate region at baseline, after 24 weeks of monotherapy with a cholinesterase inhibitor, and after another 24 weeks of combination therapy with open-label memantine and a cholinesterase inhibitor. Baseline metabolites [N-acetylaspartate (NAA), myo-inositol (mI), choline (Cho), and creatine (Cr)] and their ratios in AD subjects were compared with those of an age-matched control group of 28 cognitively normal subjects.Results
AD subjects had significantly higher mI/Cr and lower NAA, NAA/Cr, NAA/Cho, and NAA/mI.
SUBMITTER: Gordon ML
PROVIDER: S-EPMC3435529 | biostudies-literature | 2012 Jan
REPOSITORIES: biostudies-literature